Journal of Applied Biological Chemistry

The Korean Society for Applied Biological Chemistry (한국응용생명화학회)
권호 표지
DOI QR코드

DOI QR Code

Inhibitory Effect of Ni2+ on the Tolaasin-induced Hemolysis

톨라신의 용혈활성에 대한 Ni2+의 저해효과

  • Choi, Tae-Keun (Department of Agricultural Chemistry, Chungbuk National University) ;
  • Wang, Hee-Sung (Department of Agricultural Chemistry, Chungbuk National University) ;
  • Kim, Young-Kee (Department of Agricultural Chemistry, Chungbuk National University)
  • 최태근 (충북대학교 농업생명환경대학 농화학과) ;
  • 왕희성 (충북대학교 농업생명환경대학 농화학과) ;
  • 김영기 (충북대학교 농업생명환경대학 농화학과)
  • Published : 2009.03.31
Download PDF
⟨ Previous Next ⟩

Abstract

The bacterial toxin, tolaasin, causes brown blotch disease on the cultivated mushrooms by collapsing fungal and fruiting body structure of mushroom. Cytotoxicity of tolaasin was evaluated by measuring hemolytic activity because tolaasins form membrane pores on the red blood cells and destroy cell structure. While we investigated the inhibitions of hemolytic activity of tolaasin by $Zn^{2+}$ and $Cd^{2+}$, we found that $Ni^{2+}$ is another antagonist to block the toxicity of tolaasin. $Ni^{2+}$ inhibited the tolaasin-induced hemolysis in a dose-dependent manner and its Ki value was $\sim10$ mM, implying that the inhibitory effect of $Ni^{2+}$ is stronger than that of $Cd^{2+}$. The hemolytic activity was completely inhibited by $Ni^{2+}$ at the concentration higher than 50 mM. The effect of $Ni^{2+}$ was reversible since it was removed by the addition of EDTA. When the tolaasin-induced hemolysis was suppressed by the addition of 20 mM $Ni^{2+}$, the subsequent addition of EDIA immediately initiated the hemolysis. Although the mechanism of $Ni^{2+}$ -induced inhibition on tolaasin toxicity is not known, $Ni^{2+}$ could inhibit any of fallowing processes of tolaasin action, membrane binding, molecular multimerization, pore formation, and massive ion transport through the membrane pore. Our results indicate that $Ni^{2+}$ inhibits the pore activity of tolaasin, the last step of the toxic process.

세균독소인 톨라신은 재배버섯에서 버섯균사 및 자실체의 구조를 파괴하여 갈반병을 일으킨다. 톨라신의 세포독성은 톨라신이 적혈구의 세포막에 pore를 형성하여 세포구조를 파괴하기 때문에 용혈활성을 측정하여 평가한다. 저자들은 $Zn^{2+}$와 $Cd^{2+}$에 의한 톨라신의 용혈활성 저해효과를 측정하는 중에 $Ni^{2+}$이 또 다른 저해제로 톨라신의 독성을 억제하는 것을 발견하였다. $Ni^{2+}$에 의한 톨라신 용혈활성의 저해는 농도의존적이었으며, Ki 값은 대략 10mM이었고, 이것은 $Ni^{2+}$이 $Cd^{2+}$에 비하여 저해효과가 높음을 의미한다. 용혈활성은 50mM 이상의 $Ni^{2+}$농도에서 완전히 제거되었으며, $Ni^{2+}$의 효과는 EDTA 첨가에 의해 가역적임을 확인하였다. 톨라신에 의한 용혈활성이 20mM $Ni^{2+}$에 의해서 완전히 억제된 상태에서 EDTA를 가하면 즉각 용혈활성이 나타났다. $Ni^{2+}$에 의한 톨라신 독성의 저해기작은 알 수 없지만, $Ni^{2+}$은 톨라신의 독성과정인 막결합, 분자중합체 형성, pore 형성, pore를 통한 막대한 양의 이온이동 등에 작용할 수 있을 것이다. 된 연구의 결과는 $Ni^{2+}$이 독성과정의 마지막 단계인 pore를 통한 이온이동 과정을 저해함을 보여준다.

Keywords

References

  1. Bassarello C, Lazzaroni S, Bifulco G, Lo Cantore P, Iacobellis NS, Riccio R, Gomez-Paloma L, and Evidente A (2004) Tolaasins A-E, five new Iipodepsipeptides produced by Pseudomonas tolaasii. J Nat Prod 67, 811-816 https://doi.org/10.1021/np0303557
  2. Battistoni A, Pacello F, Mazzetti AP, Capo C, Kroll JS, Langford PR, Sansone A, Donnarumma G, Valenti P, and Rotilio G (2001) A histidine-rich metal binding domain at the N terminus of Cu,Zn-superoxide dismutases trom pathogenic bacteria. J BioI Chem 276, 30315-30325 https://doi.org/10.1074/jbc.M010527200
  3. Brodey CL, Rainey PB, Tester M, and Johnstone K (1991) Bacterial blotch disease of the cultivated mushroom is caused by an ion channel forming Iipodepsipeptide toxin. Mol Plant-Microbe Interact 4, 407-411 https://doi.org/10.1094/MPMI-4-407
  4. Cho KH (2003) Characterization of membrane binding and ion channel formation of a peptide toxin, tolaasin. Ph. D. Thesis. Chungbuk National University. Korea
  5. Cho KH and Kim YK (2003) Two types of ion channel formation of tolaasin, a Pseudomonas peptide toxin. FEMS Microbiol Lett 221, 221-226 https://doi.org/10.1016/S0378-1097(03)00182-4
  6. Cho KH, Kim ST, and Kim YK (2006) Inhibitory effect of $Zn^{2+}$ on tolaasin-induced hemolysis. J Korean Soc Appl BioI Chem 49, 281-286
  7. Cho KH, Kim ST, and Kim YK (2007) Purification of poreforming toxin, tolaasin, produced by Pseudomonas tolaasii 6264. J Biochem Mol BioI 40, 113-118 https://doi.org/10.5483/BMBRep.2007.40.1.113
  8. Geels FP, van Griensven LD, and Rutjens AJ (1991) Chlorine dioxide and the control of bacterial blotch on mushrooms, caused by Pseudomonas tolaasii. In Science and Cultivation of Edible Fungi (Maher ed.) Vol. 1, pp. 437-442, Balkema Pub., Brookfield, VT, USA
  9. Geels FP (1995) Pseudomonas tolaasii control by kasugamycin cultivated mushrooms (Agaricus bisporus). J Appl Bacteriol 79, 38-42 https://doi.org/10.1111/j.1365-2672.1995.tb03121.x
  10. Kim JW, Kim KH, and Kang HJ (1994) Studies on the pathogenic Pseudomonas causing bacterial disease of cultivated mushroom in Korea: I. on the causal organisms of the rots of Agaricus bisporus, Pleurotus ostreatus, and Lentinus edodes. Kor J Plant Pathol 10, 197-210
  11. Lo Cantore P, Lazzaroni S, Coraiola M, Dalla Serra M, Cafarchia C, Evidente A, and Iacobellis NS (2006) Biological characterisation of WLIP produced by Pseudomonas reactans strain NCPPBI311. Mol Plant Microbe Interact 19, 1113-1120 https://doi.org/10.1094/MPMI-19-1113
  12. Menestrina G, Moser C, Pellet S, and Welch R (1994) Poreformation by Escherichia coli hemolysin (HlyA) and other members of the RTX toxins family. Toxicol 87, 249-267 https://doi.org/10.1016/0300-483X(94)90254-2
  13. Munsch P and Oliver JM (1995) Biocontrol of bacterial blotch of the cultivated mushroom with lytic phages: some practical considerations. Mushroom Science 14, 595-602
  14. Nutkins JC, Mortishire-Smith RJ, Packman LC, Brodey CL, Rainey PB, Johnstone K, and Williams DH (1991) Structure determination of tolaasin, an extracellular Iipodepsipeptide produced by the mushroom pathogen Pseudomonas tolaasii paine. J Am Chem Soc 113, 2621-2627 https://doi.org/10.1021/ja00007a040
  15. Rainey PB, Brodey CL, and Johnstone K (1993) Identification of a gene cluster encoding three high-molecular-weight proteins, which is required for synthesis of tolaasin by the mushroom pathogen Pseudomonas tolaasii. Mol Microbiol 8, 643-652 https://doi.org/10.1111/j.1365-2958.1993.tb01608.x
  16. Shai Y (1999) Mechanism of the binding, insertion and destabilization of phospholipid bilayer membrane by a-helix antimicrobial and cell non-selective membrane-lytic peptides. Biochim Biophys Acta 1462, 55-70 https://doi.org/10.1016/S0005-2736(99)00200-X
  17. Shirata A, Sugaya K, Takasugi M, and Monde K (1995) Isolation and biological activity of toxins produced by a Japanese strain of Pseudomonas tolaasii, the pathogen of bacterial rot of cultivated oyster mushroom. Ann Phytopathol Soc Jpn 61, 493-502 https://doi.org/10.3186/jjphytopath.61.493
  18. Soler-Rivas C, Arpin N, Olivier JM, and Wichers HJ (1999) WLIP, a lipodepsipetide of Pseudomonas 'reactans' as inhibitor of the symptoms of the brown blotch disease of Agaricus bisporus. J Appl Microbiol 86, 635-641 https://doi.org/10.1046/j.1365-2672.1999.00709.x
  19. Tolaas AG (1915) A bacterial disease of cultivated mushrooms. Phytopathol 5, 51-54
  20. Wong WC and Preece TF (1985) Pseudomonas tolaasii in cultivated mushroom (Agaricus bisporus) crops effect of sodium hypochloride on the bacterium and on blotch disease severity. J Appl Bacteriol 58, 259-267 https://doi.org/10.1111/j.1365-2672.1985.tb01459.x

Cited by

  1. Microbially induced diseases of Agaricus bisporus: biochemical mechanisms and impact on commercial mushroom production vol.86, pp.1, 2010, https://doi.org/10.1007/s00253-010-2445-2
  2. Zn2+와 Ni2+에 의한 톨라신 용혈활성 저해효과의 pH 의존성 vol.61, pp.3, 2009, https://doi.org/10.3839/jabc.2018.031
  3. Dose-dependent suppression of tolaasin-induced hemolysis by gadolinium ion vol.64, pp.4, 2009, https://doi.org/10.3839/jabc.2021.050